Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,171 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sustained effect of LACTIN-V (Lactobacillus crispatus CTV-05) on genital immunology following standard bacterial vaginosis treatment: results from a randomised, placebo-controlled trial.
Armstrong E, Hemmerling A, Miller S, Burke KE, Newmann SJ, Morris SR, Reno H, Huibner S, Kulikova M, Nagelkerke N, Coburn B, Cohen CR, Kaul R. Armstrong E, et al. Lancet Microbe. 2022 Jun;3(6):e435-e442. doi: 10.1016/S2666-5247(22)00043-X. Epub 2022 Apr 21. Lancet Microbe. 2022. PMID: 35659905 Free PMC article. Clinical Trial.
Metronidazole treatment rapidly reduces genital inflammation through effects on bacterial vaginosis-associated bacteria rather than lactobacilli.
Armstrong E, Hemmerling A, Miller S, Burke KE, Newmann SJ, Morris SR, Reno H, Huibner S, Kulikova M, Liu R, Crawford ED, Castañeda GR, Nagelkerke N, Coburn B, Cohen CR, Kaul R. Armstrong E, et al. J Clin Invest. 2022 Mar 15;132(6):e152930. doi: 10.1172/JCI152930. J Clin Invest. 2022. PMID: 35113809 Free PMC article. Clinical Trial.
Treatment Success Following Standard Antibiotic Treatment for Bacterial Vaginosis Is Not Associated With Pretreatment Genital Immune or Microbial Parameters.
Armstrong E, Hemmerling A, Joag V, Huibner S, Kulikova M, Crawford E, Castañeda GR, Anzala O, Obila O, Shahabi K, Ravel J, Coburn B, Cohen CR, Kaul R. Armstrong E, et al. Open Forum Infect Dis. 2023 Jan 7;10(1):ofad007. doi: 10.1093/ofid/ofad007. eCollection 2023 Jan. Open Forum Infect Dis. 2023. PMID: 36726539 Free PMC article.
Soluble E-cadherin: A marker of genital epithelial disruption.
Liu R, Armstrong E, Constable S, Buchanan LB, Mohammadi A, Galiwango RM, Huibner S, Perry MC, Prodger JL, Coburn B, Kaul R. Liu R, et al. Among authors: armstrong e. Am J Reprod Immunol. 2023 Mar;89(3):e13674. doi: 10.1111/aji.13674. Epub 2023 Jan 12. Am J Reprod Immunol. 2023. PMID: 36593681
Quality of Life in Patients With Chronic Limb-Threatening Ischemia Treated With Revascularization.
Menard MT, Farber A, Powell RJ, Rosenfield K, Conte MS, Hamza TH, Kaufman JA, Cziraky MJ, Creager MA, Dake MD, Jaff MR, Reid D, Sopko G, White CJ, Strong MB, van Over M, Chisci E, Goodney PP, Gray B, Kayssi A, Siracuse JJ, Choudhry NK; BEST-CLI Investigators. Menard MT, et al. Circulation. 2024 Apr 16;149(16):1241-1253. doi: 10.1161/CIRCULATIONAHA.123.065277. Epub 2024 Apr 10. Circulation. 2024. PMID: 38597097 Free article. Clinical Trial.
1,171 results